John W.M. Martens

49.9k citations

328 papers · 11.9k indexed · 2 hit papers · h-index 61

Cancer Research top 0.1%
- Cancer Genomics and Diagnostics 106
- Breast Cancer Treatment Studies 24
Oncology top 0.5%
- Cancer Cells and Metastasis 52
Molecular Biology top 0.5%
- Epigenetics and DNA Methylation 24
- Molecular Biology Techniques and Applications 22
Pulmonary and Respiratory Medicine top 1%
Genetics top 1%
- BRCA gene mutations in cancer 27
- Estrogen and related hormone effects 20
Pathology and Forensic Medicine
- Genetic factors in colorectal cancer 27

Co-authors: John A. Foekens Anieta M. Sieuwerts Marcel Smid Stefan Sleijfer Jan G.M. Klijn Maxime P. Look Yixin Wang Vanja de Weerd
Cited by: Cancer Research Oncology Molecular Biology
Journals: Proceedings of the National Academy of Sciences (1 paper)Nucleic Acids Research (2 papers)Journal of Clinical Investigation (2 papers)
Partner nations: Netherlands United States Germany

In The Last Decade

John W.M. Martens

315 papers receiving 11.7k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by John W.M. Martens

Since Specialization

Citations

This map shows the geographic impact of John W.M. Martens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John W.M. Martens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John W.M. Martens more than expected).

Fields of papers citing papers by John W.M. Martens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John W.M. Martens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John W.M. Martens. The network helps show where John W.M. Martens may publish in the future.

Co-authorship network

The 25 scholars most cited alongside John W.M. Martens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John W.M. Martens Line = papers co-authored together John W.M. Martens links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Machine learning-based somatic variant calling in cell-free DNA of metastatic breast cancer patients using large NGS panels Scientific Reports ·Elisabeth M. Jongbloed,Maurice P.H.M. Jansen,Vanja de Weerd,Jean A. Helmijr,Corine M. Beaufort,Marcel Reinders,Ronald van Marion,Wilfred F. J. van IJcken,Gabe S. Sonke,Inge R. Konings,Agnes Jager,John W.M. Martens,Saskia M. Wilting,Stavros Makrodimitris	2023	2
2	mFast‐SeqS‐based aneuploidy score in circulating cell‐free DNA is a prognostic biomarker in prostate cancer Molecular Oncology ·Khrystany T. Isebia,Bianca Mostert,Teoman Deger,Jaco Kraan,Vanja de Weerd,Esther Oomen‐de Hoop,Paul Hamberg,Brigitte C.M. Haberkorn,Helgi H. Helgason,Ronald de Wit,Ron H.J. Mathijssen,Martijn P. Lolkema,Saskia M. Wilting,Job van Riet,John W.M. Martens	2023	5
3	Genomic Alterations Associated with Estrogen Receptor Pathway Activity in Metastatic Breast Cancer Have a Differential Impact on Downstream ER Signaling Cancers ·Lindsay Angus,Marcel Smid,Saskia M. Wilting,Manouk K. Bos,Neeltje Steeghs,Inge R. Konings,Vivianne C. G. Tjan‐Heijnen,J.M.G.H. van Riel,Agnès J. van de Wouw,Edwin Cuppen,Martijn P. Lolkema,Agnes Jager,Stefan Sleijfer,John W.M. Martens	2023	3
4	Expression of hypoxia-induced proteins in ductal carcinoma in situ and invasive cancer of the male breast Journal of Clinical Pathology ·Marijn A. Vermeulen,Rob B. van der Luijt,Carolien P. Schröder,John W.M. Martens,P. J. van Diest	2019	3
5	Polyomavirus T Antigen Induces APOBEC3B Expression Using an LXCXE-Dependent and TP53-Independent Mechanism mBio ·Gabriel J. Starrett,Artur A. Serebrenik,Pieter A. Roelofs,Jennifer L. McCann,Brandy Verhalen,Matthew C. Jarvis,Teneale A. Stewart,Emily K. Law,Annabel Krupp,Mengxi Jiang,John W.M. Martens,Ellen Cahir-McFarland,Paul N. Span,Reuben S. Harris	2019	32
6	Clonality, Antigen Recognition, and Suppression of CD8+ T Cells Differentially Affect Prognosis of Breast Cancer Subtypes Clinical Cancer Research ·Dora Hammerl,Maarten P.G. Massink,Marcel Smid,Carolien H. M. van Deurzen,Hanne Meijers‐Heijboer,Quinten Waisfisz,Reno Debets,John W.M. Martens	2019	37
7	Interferon-Stimulated Genes Are Involved in Cross-resistance to Radiotherapy in Tamoxifen-Resistant Breast Cancer Clinical Cancer Research ·Annemarie E.M. Post,Marcel Smid,Anika Nagelkerke,John W.M. Martens,Johan Bussink,Fred C.G.J. Sweep,Paul N. Span	2018	64
8	Functional Ex Vivo Assay Reveals Homologous Recombination Deficiency in Breast Cancer Beyond BRCA Gene Defects Clinical Cancer Research ·Titia G. Meijer,Nicole S. Verkaik,Anieta M. Sieuwerts,Job van Riet,Kishan A.T. Naipal,Carolien H. M. van Deurzen,Michael A. den Bakker,Hein F.B.M. Sleddens,Hendrikus-Jan Dubbink,T. Dorine den Toom,Winand N.M. Dinjens,Esther H. Lips,Petra M. Nederlof,Marcel Smid,Harmen J.G. van de Werken,Roland Kanaar,John W.M. Martens,Agnes Jager,Dik C. van Gent	2018	47
9	A Systematic Analysis of Oncogenic Gene Fusions in Primary Colon Cancer Cancer Research ·Wigard P. Kloosterman,Robert R.J. Coebergh van den Braak,Mark Pieterse,Markus J. van Roosmalen,Anieta M. Sieuwerts,Christina Stangl,Ronne Brunekreef,Zarina S. Lalmahomed,Salo Ooft,Anne van Galen,Marcel Smid,Armel Lefebvre,Fried Zwartkruis,John W.M. Martens,John A. Foekens,Katharina Biermann,Marco J. Koudijs,Jan N.M. IJzermans,Emile E. Voest	2017	67
10	Low Tumor Mitochondrial DNA Content Is Associated with Better Outcome in Breast Cancer Patients Receiving Anthracycline-Based Chemotherapy Clinical Cancer Research ·Marjolein J.A. Weerts,Antoinette Hollestelle,Anieta M. Sieuwerts,John A. Foekens,Stefan Sleijfer,John W.M. Martens	2017	16
11	APOBEC3G Expression Correlates with T-Cell Infiltration and Improved Clinical Outcomes in High-grade Serous Ovarian Carcinoma Clinical Cancer Research ·Brandon Leonard,Gabriel J. Starrett,Matthew J. Maurer,Ann L. Oberg,Mieke Van Bockstal,Jo Van Dorpe,Olivier De Wever,Jozien Helleman,Anieta M. Sieuwerts,Els M.J.J. Berns,John W.M. Martens,Brett D. Anderson,William L. Brown,Kimberly R. Kalli,Scott H. Kaufmann,Reuben S. Harris	2016	52
12	Improved Circulating Tumor Cell Detection by a Combined EpCAM and MCAM CellSearch Enrichment Approach in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy Molecular Cancer Therapeutics ·Wendy Onstenk,Jaco Kraan,Bianca Mostert,Mieke M. Timmermans,Ayoub Charehbili,Vincent T.H.B.M. Smit,Judith R. Kroep,J.W.R. Nortier,Saskia van de Ven,Joan B. Heijns,Lonneke W. Kessels,Hanneke W.M. van Laarhoven,Monique M.E.M. Bos,Cornelis J.�H. van de Velde,Jan W. Gratama,Anieta M. Sieuwerts,John W.M. Martens,John A. Foekens,Stefan Sleijfer	2014	47
13	Selection of Personalized Patient Therapy through the Use of Knowledge-Based Computational Models That Identify Tumor-Driving Signal Transduction Pathways Cancer Research ·Wim Verhaegh,Henk van Ooijen,Márcia A. Inda,Pantelis Hatzis,Rogier Versteeg,Marcel Smid,John W.M. Martens,John A. Foekens,Paul van de Wiel,Hans Clevers,Anja van de Stolpe	2014	62
14	Functional Ex Vivo Assay to Select Homologous Recombination–Deficient Breast Tumors for PARP Inhibitor Treatment Clinical Cancer Research ·Kishan A.T. Naipal,Nicole S. Verkaik,Najim Ameziane,Carolien H. M. van Deurzen,Petra ter Brugge,Matty Meijers,Anieta M. Sieuwerts,John W.M. Martens,Mark J. O’Connor,Harry Vrieling,Jan H.J. Hoeijmakers,Jos Jonkers,Roland Kanaar,Johan P. de Winter,Maaike P.G. Vreeswijk,Agnes Jager,Dik C. van Gent	2014	124
15	Validation of a Radiosensitivity Molecular Signature in Breast Cancer Clinical Cancer Research ·Steven A. Eschrich,William J. Fulp,Yudi Pawitan,John A. Foekens,Marcel Smid,John W.M. Martens,Michelle Echevarria,Vidya Kamath,Ji‐Hyun Lee,Eleanor Harris,Jonas Bergh,Javier F. Torres–Roca	2012	145
16	FOXC1 Is a Potential Prognostic Biomarker with Functional Significance in Basal-like Breast Cancer Cancer Research ·Partha Ray,Jinhua Wang,Ying Qu,Myung‐Shin Sim,Jaime Shamonki,Sanjay P. Bagaria,Xing Ye,Bingya Liu,David Elashoff,Dave S.�B. Hoon,Michael A. Walter,John W.M. Martens,Andrea L. Richardson,Armando E. Giuliano,Xiaojiang Cui	2010	199
17	Copy Number Alterations that Predict Metastatic Capability of Human Breast Cancer Cancer Research ·Yi Zhang,John W.M. Martens,Jack X. Yu,John Jiang,Anieta M. Sieuwerts,Marcel Smid,Jan G.M. Klijn,Yixin Wang,John A. Foekens	2009	70
18	DNA Methylation Markers Predict Outcome in Node-Positive, Estrogen Receptor-Positive Breast Cancer with Adjuvant Anthracycline-Based Chemotherapy Clinical Cancer Research ·Oliver Hartmann,Frédérique Spyratos,Nadia Harbeck,Dimo Dietrich,Anne Faßbender,Manfred Schmitt,Serenella Eppenberger‐Castori,Vincent Vuaroqueaux,Florence Lerebours,Katrin Welzel,Sabine Maier,Achim Plum,Stephan Niemann,John A. Foekens,Ralf Lesche,John W.M. Martens	2008	79
19	Subtypes of Breast Cancer Show Preferential Site of Relapsebreakdown → Cancer Research ·Marcel Smid,Yixin Wang,Yi Zhang,Anieta M. Sieuwerts,Jack X. Yu,Jan G.M. Klijn,John A. Foekens,John W.M. Martens	2008	622
20	Association of DNA Methylation of Phosphoserine Aminotransferase with Response to Endocrine Therapy in Patients with Recurrent Breast Cancer Cancer Research ·John W.M. Martens,Inko Nimmrich,Thomas Koenig,Maxime P. Look,Nadia Harbeck,Fabian Model,Antje Kluth,Joan Bolt‐de Vries,Anieta M. Sieuwerts,Henk Portengen,Marion E. Meijer‐van Gelder,Christian Piepenbrock,Alexander Olek,Heinz Höfler,Marion Kiechle,Jan G.M. Klijn,Manfred Schmitt,Sabine Maier,John A. Foekens	2005	102

About John W.M. Martens

John W.M. Martens is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 328 papers that have together received 11.9k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (106 papers), Cancer Cells and Metastasis (52 papers), BRCA gene mutations in cancer (27 papers), Genetic factors in colorectal cancer (27 papers), Breast Cancer Treatment Studies (24 papers), Epigenetics and DNA Methylation (24 papers), Molecular Biology Techniques and Applications (22 papers) and Estrogen and related hormone effects (20 papers). The work is most often cited by research in Cancer Research (4.8k citations), Oncology (4.4k citations) and Molecular Biology (6.8k citations). John W.M. Martens has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include John A. Foekens, Anieta M. Sieuwerts, Marcel Smid, Stefan Sleijfer, Jan G.M. Klijn, Maxime P. Look, Yixin Wang, Vanja de Weerd, Jaco Kraan and Jack X. Yu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact